NGM Bio Announces Multiple Presentations at The International Liver Congress™ 2019

NEXT STORY
Chimerix Announces Management Updates
PREV STORY
Translate Bio Presents Preclinical Data Supporting MRT5201 for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency at the Society for Inherited Metabolic Disorders (SIMD) Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Humanigen Appoints Robert Savage to Board of Directors

BRISBANE, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company ...

author_avatar
NASDAQ Market News

Aptose Biosciences to Participate at the Bloom Burton & Co. Healthcare Investor Conference 2017

SAN DIEGO and TORONTO, April 25, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO), ...

author_avatar
NASDAQ Market News

FIT Biotech Oy: Conversion of FIT Biotech Oy’s Convertible Capital Notes into shares

FIT Biotech Oy Company release September 26, 2017 at 10:00 AM EET Conversion of ...

author_avatar
NASDAQ Market News